David A Garrison
Insider
First SEC filing: July 3, 2025 · Latest: July 3, 2025
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 2, 2025 | HHS | A | 25,000 | $4.55 | $113,750 | 25,000 Indirect | · | Acquired | 0.2% (price as of 2026-10-02) |
| Nov. 25, 2024 | HHS | P | 850 | $5.80 | $4,930 | 13,129 Indirect | +6.92% | Acquired | -21.4% (price as of 2026-10-02) |
| Nov. 18, 2024 | HHS | P | 25 | $6.54 | $164 | 12,279 Indirect | +0.20% | Acquired | -30.3% (price as of 2026-10-02) |
| Nov. 18, 2024 | HHS | P | 45 | $6.54 | $294 | 12,254 Indirect | +0.37% | Acquired | -30.3% (price as of 2026-10-02) |
| Nov. 18, 2024 | HHS | P | 69 | $6.59 | $455 | 12,209 Indirect | +0.57% | Acquired | -30.8% (price as of 2026-10-02) |
| Nov. 18, 2024 | HHS | P | 1,500 | $6.50 | $9,750 | 12,140 Indirect | +14.10% | Acquired | -29.8% (price as of 2026-10-02) |
| Nov. 18, 2024 | HHS | P | 1,441 | $6.60 | $9,511 | 10,640 Indirect | +15.66% | Acquired | -30.9% (price as of 2026-10-02) |
| Nov. 18, 2024 | HHS | P | 765 | $6.65 | $5,087 | 9,199 Indirect | +9.07% | Acquired | -31.4% (price as of 2026-10-02) |
| Nov. 18, 2024 | HHS | P | 59 | $6.40 | $378 | 8,434 Indirect | +0.70% | Acquired | -28.8% (price as of 2026-10-02) |
| Aug. 12, 2024 | HHS | P | 100 | $6.86 | $686 | 8,375 Indirect | +1.21% | Acquired | -33.5% (price as of 2026-10-02) |
| Aug. 12, 2024 | HHS | P | 400 | $6.92 | $2,768 | 8,275 Indirect | +5.08% | Acquired | -34.1% (price as of 2026-10-02) |
| Aug. 12, 2024 | HHS | P | 3,750 | $7.05 | $26,438 | 7,875 Indirect | +90.91% | Acquired | -35.3% (price as of 2026-10-02) |
| May 13, 2024 | HHS | P | 4,125 | $7.20 | $29,700 | 4,125 Indirect | · | Acquired | -36.7% (price as of 2026-10-02) |
| Jan. 30, 2024 | HHS | A | 64,600 | $7.74 | $500,004 | 64,600 Direct | · | Acquired | -41.1% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 30, 2024 | HHS | Option to buy Common Shares | Common Stock | $7.74 | Jan. 29, 2034 | 64,600 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $375,000 | · | $113,750 | · | · | · | $13,200 | $501,950 |
| 2024 | $396,542 | · | $335,646 | · | · | · | $12,115 | $744,303 |
| 2023 | $150,400 | · | · | · | · | · | · | $150,400 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.